Document is current
Any future updates will be listed below
-
Authors
Gagne, Matthew
Flynn, Barbara J.
Honeycutt, Christopher Cole
Flebbe, Dillon R.
Andrew, Shayne F. http://orcid.org/0000-0001-7226-7757
Provost, Samantha J. http://orcid.org/0009-0008-4413-5923
McCormick, Lauren http://orcid.org/0000-0003-4928-3008
Van Ry, Alex http://orcid.org/0000-0002-1240-9044
McCarthy, Elizabeth
Todd, John-Paul M.
Bao, Saran
Teng, I-Ting
Marciano, Shir http://orcid.org/0000-0001-8506-9549
Rudich, Yinon http://orcid.org/0000-0003-3149-0201
Li, Chunlin
Jain, Shilpi
Wali, Bushra
Pessaint, Laurent
Dodson, Alan
Cook, Anthony
Lewis, Mark G. http://orcid.org/0000-0001-7852-0135
Andersen, Hanne http://orcid.org/0000-0003-1103-9608
Zahradník, Jiří http://orcid.org/0000-0002-8698-4236
Suthar, Mehul S. http://orcid.org/0000-0002-2686-8380
Nason, Martha C. http://orcid.org/0000-0002-0110-881X
Foulds, Kathryn E. http://orcid.org/0000-0003-4418-6495
Kwong, Peter D. http://orcid.org/0000-0003-3560-232X
Roederer, Mario
Schreiber, Gideon http://orcid.org/0000-0002-2922-5882
Seder, Robert A. http://orcid.org/0000-0003-3133-0849
Douek, Daniel C. http://orcid.org/0000-0001-5575-8634
- License Information
-
More Information
Article History
Received: 21 November 2023
Accepted: 29 July 2024
First Online: 12 August 2024
Competing interests
: The authors declare the following competing interests: M.S.S. serves on the scientific board of advisors for Moderna and Ocugen. D.C.D. is an inventor on US Patent Application No. 63/147,419 entitled “Antibodies Targeting the Spike Protein of Coronaviruses”. A.V.R., L.P., A.D., A.C., M.G.L. and H.A. are employees of Bioqual. The other authors declare no competing interests.
